Internal Medicine, Nephrology · Melrose Park, IL
NPI
1275568578
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
675 W North Ave Ste 309
Melrose Park, IL, 60160
Phone (312) 654-2744
Groups this clinician bills Medicare through
Medicare paid, 2024
$238K
2,615 services
Medicare patients, 2024
503
Average age 77
Drug cost, 2024
$749K
1,896 prescriptions
Company payments, 2025
$704
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rizwan K Moinuddin was code 99233 (hospital e&m - subsequent), 729 times for 146 patients. In total Rizwan K Moinuddin billed 2,615 services in 34 codes, and Medicare paid $238K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 729 | 146 | $87.08 | $63K |
| 99232 Hospital E&M - Subsequent | Facility | 335 | 91 | $58.95 | $20K |
| 99214 Office E&M - Established | Office | 296 | 114 | $75.09 | $22K |
| 99223 Hospital E&M - Initial | Facility | 206 | 165 | $127.03 | $26K |
| 99310 SNF E&M | Facility | 160 | 79 | $113.10 | $18K |
| 99306 SNF E&M | Facility | 113 | 109 | $133.83 | $15K |
| 90961 ESRD Related Services (not dialysis) | Office | 104 | 18 | $216.63 | $23K |
| 90962 ESRD Related Services (not dialysis) | Office | 31 | 13 | $149.59 | $4,637 |
| 99204 Office E&M - New | Office | 30 | 30 | $119.33 | $3,580 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 26 | 11 | $12.10 | $314 |
| J3010 Injection, fentanyl citrate, 0.1 mg | Office | 24 | 12 | $0.75 | $17.92 |
| 99213 Office E&M - Established | Office | 19 | 16 | $60.53 | $1,150 |
| 90960 ESRD Related Services (not dialysis) | Office | 19 | 13 | $239.91 | $4,558 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 18 | 12 | $0.11 | $1.99 |
| 99152 Anesthesia | Office | 12 | 12 | $36.79 | $442 |
By year: 2022 $286K for 3,026 services; 2023 $269K for 2,268 services; 2024 $238K for 2,615 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rizwan K Moinuddin prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 122 prescriptions and refills. In total Rizwan K Moinuddin wrote 1,896 Medicare prescriptions that cost $749K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 122 | 208 | 30 | $113K |
| Amlodipine Besylate Generic | 117 | 313 | 46 | $1,157 |
| Losartan Potassium Generic | 106 | 297 | 38 | $1,368 |
| Bumetanide Generic | 105 | 206 | 38 | $3,520 |
| Furosemide Generic | 102 | 168 | 31 | $437 |
| Allopurinol Generic | 80 | 224 | 34 | $725 |
| Sevelamer Carbonate Generic | 77 | 137 | 21 | $19K |
| Torsemide Generic | 73 | 136 | 31 | $1,459 |
| Hydralazine Hcl Generic | 71 | 181 | 29 | $1,686 |
| Hydrochlorothiazide Generic | 64 | 175 | 24 | $432 |
| Jardiance Empagliflozin | 59 | 135 | 24 | $78K |
| Carvedilol Generic | 57 | 166 | 21 | $534 |
| Lisinopril Generic | 41 | 109 | 15 | $294 |
| Midodrine Hcl Generic | 38 | 67 | 19 | $2,547 |
| Spironolactone Generic | 34 | 81 | 13 | $365 |
Brand drugs: 365 claims; generic drugs: 1,531 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rizwan K Moinuddin $704 ($704 in general payments such as food, travel and fees) from 9 companies. The largest payer was Calliditas Therapeutics US Inc. with $162.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $124 |
| Fresenius USA Marketing, Inc. | 5 | $111 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $72.44 |
| Travere Therapeutics, Inc. TVTX | 2 | $55.56 |
| Aurinia Pharma U.S., Inc. AUPH | 1 | $53.74 |
| Lilly USA, LLC LLY | 2 | $44.26 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.87 |
| Ardelyx, Inc. ARDX | 2 | $37.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.